- Molina’s 2Q Adjusted EPS: $5.86, surpassing the previous year’s $5.65 and beating the estimate of $5.59.
- Revenue: $9.88 billion, marking a 19% increase year-over-year, and exceeding the estimate of $9.79 billion.
- Medical Care Ratio: 88.6% compared to last year’s 87.5%.
- Full Year 2024 Guidance: The company reaffirmed its guidance, expecting premium revenue of approximately $38 billion.
- Expected Full Year Adjusted Earnings: At least $23.50 per diluted share.
- Premium Revenue Growth: Expected to increase by approximately 17% from full year 2023.
- Rate Adjustments: Known rate adjustments in the second half of the year are expected to largely offset the higher expected trend.
- Analyst Ratings: 6 buys, 9 holds, and 1 sell.
Molina Healthcare on Smartkarma
Analysts on Smartkarma are closely covering Molina Healthcare, with Baptista Research recently initiating coverage on the company with a bullish sentiment. In their report titled “Molina Healthcare Inc.: Initiation of Coverage – A Story Of Enhanced Focus on Managed Medicaid and Medicare Advantage Expansion! – Major Drivers,” Baptista Research highlighted Molina Healthcare‘s first-quarter earnings, where they achieved an adjusted EPS of $5.73 and generated $9.5 billion in premium revenue. The company’s performance was described as meeting expectations, supported by efficient operating metrics across all business segments, with a consolidated MCR (medical cost ratio) at 88.5%, showcasing strong medical cost management in line with the company’s forecasts.
A look at Molina Healthcare Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 3 | |
Dividend | 1 | |
Growth | 4 | |
Resilience | 4 | |
Momentum | 2 | |
OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Molina Healthcare shows a promising long-term outlook. With strong scores in Growth and Resilience, the company is positioned well for future expansion and stability in the volatile healthcare sector. While the Value score is moderate, indicating a fair valuation, Molina Healthcare‘s focus on growth and ability to weather challenges suggest a positive trajectory ahead. However, the lower scores in Dividend and Momentum indicate areas that may need attention to fully optimize the company’s performance.
Molina Healthcare Inc., a managed care organization focusing on delivering healthcare services to low-income families, demonstrates solid potential for growth and resilience in the long term. Operating health plans in multiple states and incorporating primary care clinics, Molina Healthcare‘s strategic positioning aligns with its strong Growth and Resilience scores. Despite some room for improvement in Dividend and Momentum aspects, the company’s core focus on providing essential services to underserved populations underscores its commitment to societal impact and long-term sustainability.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars